These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21535475)

  • 1. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.
    Brosnahan AJ; Schlievert PM
    FEBS J; 2011 Dec; 278(23):4649-67. PubMed ID: 21535475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolysins augment superantigen penetration of stratified mucosa.
    Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
    J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to staphylococcal superantigens.
    Krakauer T
    Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel toxic shock syndrome toxin-1 amino acids required for biological activity.
    Brosnahan AJ; Schaefers MM; Amundson WH; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
    Biochemistry; 2008 Dec; 47(49):12995-3003. PubMed ID: 19012411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic shock syndrome and bacterial superantigens: an update.
    McCormick JK; Yarwood JM; Schlievert PM
    Annu Rev Microbiol; 2001; 55():77-104. PubMed ID: 11544350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of streptococcal and staphylococcal superantigens in septic shock.
    Bannan J; Visvanathan K; Zabriskie JB
    Infect Dis Clin North Am; 1999 Jun; 13(2):387-96, ix. PubMed ID: 10340173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.
    Lin YC; Anderson MJ; Kohler PL; Strandberg KL; Olson ME; Horswill AR; Schlievert PM; Peterson ML
    Biochemistry; 2011 Aug; 50(33):7157-67. PubMed ID: 21749039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bacterial superantigen and superantigen-like proteins.
    Fraser JD; Proft T
    Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal Models Used to Study Superantigen-Mediated Diseases.
    Brosnahan AJ
    Methods Mol Biol; 2016; 1396():1-17. PubMed ID: 26676033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
    Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
    Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.
    Chau TA; McCully ML; Brintnell W; An G; Kasper KJ; Vinés ED; Kubes P; Haeryfar SM; McCormick JK; Cairns E; Heinrichs DE; Madrenas J
    Nat Med; 2009 Jun; 15(6):641-8. PubMed ID: 19465927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular structure of staphylococcus and streptococcus superantigens.
    Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
    J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
    Alouf JE; Müller-Alouf H
    Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen antagonist peptides.
    Llewelyn M; Cohen J
    Crit Care; 2001; 5(2):53-5. PubMed ID: 11299061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
    Ramachandran G; Tulapurkar ME; Harris KM; Arad G; Shirvan A; Shemesh R; Detolla LJ; Benazzi C; Opal SM; Kaempfer R; Cross AS
    J Infect Dis; 2013 Jun; 207(12):1869-77. PubMed ID: 23493729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gram-positive toxic shock syndromes.
    Lappin E; Ferguson AJ
    Lancet Infect Dis; 2009 May; 9(5):281-90. PubMed ID: 19393958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
    Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
    mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigens: microbial agents that corrupt immunity.
    Llewelyn M; Cohen J
    Lancet Infect Dis; 2002 Mar; 2(3):156-62. PubMed ID: 11944185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.